Evidence map›Paper›PMID 20103729›Full record

ArticleCancer prevention research (Philadelphia, Pa.)2010

Chemoprevention of B-cell lymphomas by inhibition of the Myc target spermidine synthase.

TachaZi Plym Forshell, Sara Rimpi, Jonas A Nilsson

Abstract read
PubMed Publisher
In one paragraph

Article in Cancer prevention research (Philadelphia, Pa.), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. A Novel Polyamine-Targeted Therapy for BRAF Mutant Melanoma Tumors.Medical sciences (Basel, Switzerland) · 2018
    Article
  14. Review
  15. Review
  16. Article
  17. Targeting MYC in cancer therapy: RNA processing offers new opportunities.BioEssays : news and reviews in molecular, cellular and developmental biology · 2016
    Review
  18. Targeting polyamine biosynthetic pathway through RNAi causes the abrogation of MCF 7 breast cancer cell line.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

TachaZi Plym ForshellDepartment of Molecular Biology, Umeå University, Sweden.
Sara Rimpi
Jonas A Nilsson
Umeå University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The oncogenic transcription factor c-Myc (Myc) is frequently overexpressed in human cancers. Myc is known to induce or repress a large set of genes involved in cell growth and proliferation, explaining the selection for mutations in cancer that deregulate Myc expression. Inhibition of ornithine decarboxylase, an enzyme of the polyamine biosynthetic pathway and a Myc target, has been shown to be chemopreventive. In the present study, we have dissected the role of another enzyme in the polyamine biosynthetic pathway, spermidine synthase (Srm), in Myc-induced cancer. We find that Srm is encoded by a Myc target gene containing perfect E-boxes and that it is induced by Myc in a direct manner. RNA interference against Srm shows that it is important for Myc-induced proliferation of mouse fibroblasts but to a lesser extent for transformation. Using the compound trans-4-methylcyclohexylamine, we show that Srm inhibition can delay the onset of B-cell lymphoma development in lambda-Myc transgenic mice. We therefore suggest that inhibition of Srm is an additional chemopreventive strategy that warrants further consideration.

Indexed as

3T3 CellsAnimalsAntineoplastic AgentsCell ProliferationChemopreventionCyclohexylaminesHumansLymphoma, B-CellMiceMice, Inbred C57BLMice, TransgenicProto-Oncogene Proteins c-mycReverse Transcriptase Polymerase Chain ReactionRNA InterferenceSignal TransductionSpermidine Synthase4-methylcyclohexylamineAntineoplastic AgentsCyclohexylaminesProto-Oncogene Proteins c-mycSpermidine Synthase

Identifiers

PMID20103729
OpenAlexW2158321124

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.